Cite

HARVARD Citation

    Tokaca, N. et al. (n.d.). Real-world outcomes with pembrolizumab in patients with treatment-naive advanced/metastatic NSCLC in the UK: multicentre retrospective observational study. Lung cancer. pp. S33-S34. [Online]. 
  
Back to record